Seattle Archives

PCa Commentary | Volume 156 – August 2021

Posted by Edward Weber, MD | Aug 2021

This Commentary looks at Pylarify, a new PET/CT imaging agent for staging primary prostate cancer and recurrence.

PCa Commentary | Volume 155 – July 2021

Posted by Edward Weber, MD | Jul 2021

This Commentary looks at causes and management options for hot flashes, a common side effect of ADT treatment for prostate cancer.

PCa Commentary | Volume 154 – June 2021

Posted by Edward Weber, MD | Jun 2021

This Commentary looks at the current state of causes, diagnosis and treatment for neuroendocrine prostate cancer.

PCa Commentary | Volume 153 – May 2021

Posted by Edward Weber, MD | May 2021

This Commentary provides an overview of PSMA-targeted radioligand therapy with Lutetium-177 or Actinium-225 and positive impact on progression-free survival.

PCa Commentary | Volume 152 – April 2021

Posted by Edward Weber, MD | Apr 2021

This Commentary provides a primer on using genomic classifiers and genomic sequencing to guide management decisions for prostate cancer.